{
    "name": "finafloxacin otic",
    "comment": "Discontinued",
    "other_names": [
        "Xtoro"
    ],
    "classes": [
        "Antibiotics",
        "Otic",
        "Quinolones",
        "Otic"
    ],
    "source": "https://reference.medscape.com/drug/xtoro-finafloxacin-otic-999986",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Shown to be teratogenic in rabbits and rats following oral administration; neural tube defects and skeletal anomalies in both species, and limb anomalies in rabbits, were observed at exposures estimated to be at least 1300 times the maximum human systemic exposure following topical otic administration of 0.3% finafloxacin",
            "Because animal studies are not always predictive of human responses, use during pregnancy only if the potential benefit justifies the potential risk to the fetus"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Identified in the milk of nursing rats following oral administration",
            "The human systemic concentration following topical otic treatment is low; it is not known whether topical otic administration could result in sufficient systemic absorption to produce detectable quantities in the human breast milk",
            "Caution should be exercised when finafloxacin is administered to a nursing mother"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "As with other antibacterial preparations, prolonged use may result in overgrowth of resistant organisms including yeast and fungi",
                "Allergic reactions may occur in patients with a history of hypersensitivity to finafloxacin, to other quinolones, or to any of the components in this medication; if allergic reaction occurs, discontinue use and institute alternative therapy"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Pruritus",
            "percent": "1"
        },
        {
            "name": "Nausea",
            "percent": "1"
        }
    ]
}